Topoisomerase II beta levels are a determinant of melphalan-induced DNA crosslinks and sensitivity to cell death

被引:16
作者
Emmons, M.
Boulware, D.
Sullivan, D. M.
Hazlehurst, L. A.
机构
[1] Univ S Florida, Expt Therapeut Program, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] Univ S Florida, Dept Interdisciplinary Oncol, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[3] Univ S Florida, Biostat Core Program, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
关键词
DNA repair; topoisomerase II alpha; topoisomerase II beta; alkylating agents; crosslinks; drug resistance;
D O I
10.1016/j.bcp.2006.03.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of topoisomerase (topo) II in DNA repair has yet to be fully elucidated. Current evidence suggesting a role for topo II in the repair of DNA damage has been obtained by using in vitro model systems or infer-red from correlative data in drug resistant cell lines. In this study we directly examined the role of topo II alpha and beta in mediating the repair of melphalan-induced crosslinks in cellular DNA. To accomplish this, we used siRNA technology to knock down either topo II alpha or beta in human chronic myelogenous leukemia K562 and histiocytic lymphoma U937 cell line. Our data demonstrate that topo II beta levels, (but not alpha), are a determinant of melphalan-induced crosslinks and sensitivity to melphalan. Furthermore, we show that knocking down topo II beta inhibits the repair of melphalan-induced crosslinks in K562 cells. These studies represent the first direct evidence that topo II beta participates in the repair of DNA damage induced by an alkylating agent in cellular DNA. Finally, these results suggest non-redundant roles for these two isoforms in mediating repair of DNA crosslinks. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:11 / 18
页数:8
相关论文
共 20 条
[1]   Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα [J].
Akimitsu, N ;
Adachi, N ;
Hirai, H ;
Hossain, MS ;
Hamamoto, H ;
Kobayashi, M ;
Aratani, Y ;
Koyama, H ;
Sekimizu, K .
GENES TO CELLS, 2003, 8 (04) :393-402
[2]  
BARRET JM, 1994, MOL PHARMACOL, V46, P431
[3]   BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS [J].
BEDI, A ;
BARBER, JP ;
BEDI, GC ;
ELDEIRY, WS ;
SIDRANSKY, D ;
VALA, MS ;
AKHTAR, AJ ;
HILTON, J ;
JONES, RJ .
BLOOD, 1995, 86 (03) :1148-1158
[4]   The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells [J].
Chen, Q ;
Van der Sluis, PC ;
Boulware, D ;
Hazlehurst, LA ;
Dalton, WS .
BLOOD, 2005, 106 (02) :698-705
[5]   The Fanconi Anemia/BRCA Signaling Pathway Disruption in Cisplatin-Sensitive Ovarian Cancers [J].
D'Andrea, Alan D. .
CELL CYCLE, 2003, 2 (04) :290-292
[6]   An essential function for NBS1 in the prevention of ataxia and cerebellar defects [J].
Frappart, PO ;
Tong, WM ;
Demuth, I ;
Radovanovic, I ;
Herceg, Z ;
Aguzzi, A ;
Digweed, M ;
Wang, ZQ .
NATURE MEDICINE, 2005, 11 (05) :538-544
[7]  
Hazlehurst LA, 2003, CANCER RES, V63, P7900
[8]   Adhesion to fibronectin via β1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR) [J].
Hazlehurst, LA ;
Damiano, JS ;
Buyuksal, I ;
Pledger, WJ ;
Dalton, WS .
ONCOGENE, 2000, 19 (38) :4319-4327
[9]   Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm [J].
Lee, Y ;
Barnes, DE ;
Lindahl, T ;
McKinnon, PJ .
GENES & DEVELOPMENT, 2000, 14 (20) :2576-2580
[10]   Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIβ [J].
Lyu, YL ;
Wang, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7123-7128